Nomenclature
EC number
3.5.1.99
Systematic name
fatty acylamide amidohydrolase
Recommended name
fatty acid amide hydrolase
Synonyms
AAH <3> [15]
FAAH <1,2,3,4,5,6,7,8> [1,2,3,5,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,24,25,26,27,28,29]
FAAH-1 <6,7,8> [6]
FAAH-2 <2,9> (<9> FAAH-2 is an ancient gene present in primates, but not murids [6]) [6,24]
anandamide amidohydrolase <3> [12,15]
endocannabinoid-degrading enzyme <3> [27]
fatty acid amide hydrolase <3,9> [23]
fatty-acid amide hydrolase <3> [17]
oleamide hydrolase <3> [12,17]
CAS registry number
153301-19-0
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Patricelli, M.P.; Lashuel, H.A.; Giang, D.K.; Kelly, J.W.; Cravatt, B.F.: Comparative characterization of wild type and transmembrane domain-deleted fatty acid amide hydrolase identification of the transmembrane domain as a site for oligomerization. Biochemistry, 37, 15177-15187 (1998)
Vandevoorde, S.; Fowler, C.J.: Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate. Br. J. Pharmacol., 145, 885-893 (2005)
Quistad, G.B.; Klintenberg, R.; Caboni, P.; Liang, S.N.; Casida, J.E.: Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation of brain 2-arachidonoylglycerol and the associated hypomotility in mice. Toxicol. Appl. Pharmacol., 211, 78-83 (2006)
Cisneros, J.A.; Vandevoorde, S.; Ortega-Gutierrez, S.; Paris, C.; Fowler, C.J.; Lopez-Rodriguez, M.L.: Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis - comparison with effects upon fatty acid amide hydrolase. J. Med. Chem., 50, 5012-5023 (2007)
Muccioli, G.G.; Xu, C.; Odah, E.; Cudaback, E.; Cisneros, J.A.; Lambert, D.M.; Lopez Rodriguez, M.L.; Bajjalieh, S.; Stella, N.: Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells. J. Neurosci., 27, 2883-2889 (2007)
Wei, B.Q.; Mikkelsen, T.S.; McKinney, M.K.; Lander, E.S.; Cravatt, B.F.: A second fatty acid amide hydrolase with variable distribution among placental mammals. J. Biol. Chem., 281, 36569-36578 (2006)
Fowler, C.J.; Jonsson, K.O.; Tiger, G.: Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide. Biochem. Pharmacol., 62, 517-26 (2001)
Patricelli, M.P.; Cravatt, B.F.: Fatty acid amide hydrolase competitively degrades bioactive amides and esters through a nonconventional catalytic mechanism. Biochemistry, 38, 14125-14130 (1999)
Patricelli M.P.; Lovato, M.A.; Cravatt, B.F.: Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties. Biochemistry, 38, 9804-9812 (1999)
Patricelli, M.P.; Cravatt, B.F.: Characterization and manipulation of the acyl chain selectivity of fatty acid amide hydrolase. Biochemistry, 40, 6107-6115 (2001)
Ferreri, C.; Anagnostopoulos, D.; Lykakis, I.N.; Chatgilialoglu, C.; Siafaka-Kapadai, A.: Synthesis of all-trans anandamide: A substrate for fatty acid amide hydrolase with dual effects on rabbit platelet activation. Bioorg. Med. Chem., 16, 8359-8365 (2008)
Boger, D.L.; Fecik, R.A.; Patterson, J.E.; Miyauchi, H.; Patricelli, M.P.; Cravatt, B.F.: Fatty acid amide hydrolase substrate specificity. Bioorg. Med. Chem. Lett., 10, 2613-2616 (2000)
Lodola, A.; Mor, M.; Hermann, J.C.; Tarzia, G.; Piomelli, D.; Mulholland, A.J.: QM/MM modelling of oleamide hydrolysis in fatty acid amide hydrolase (FAAH) reveals a new mechanism of nucleophile activation. Chem. Commun. (Camb.), 35, 4399-401 (2005)
Patricelli, M.P.; Cravatt, B.F.: Clarifying the catalytic roles of conserved residues in the amidase signature family. J. Biol. Chem., 275, 19177-19184 (2000)
Lang, W.; Qin, C.; Lin, S.; Khanolkar, A.D.; Goutopoulos, A.; Fan, P.; Abouzid, K.; Meng, Z.; Biegel, D.; Makriyannis, A.: Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase. J. Med. Chem., 42, 898-902 (1999)
Romero, F.A.; Du, W.; Hwang, I.; Rayl, T.J.; Kimball, F.S.; Leung, D.; Hoover, H.S.; Apodaca, R.L.; Breitenbucher, J.G.; Cravatt, B.F.; Boger, D.L.J.: Potent and selective α-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase. J. Med. Chem., 50, 1058-68 (2007)
Cravatt, B.F.; Giang, D.K.; Mayfield, S.P.; Boger, D.L.; Lerner, R.A.; Gilula, N.B.: Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature, 384, 83-87 (1996)
Egertova, M.; Cravatt, B.F.; Elphick, M.R.: Fatty acid amide hydrolase expression in rat choroid plexus: possible role in regulation of the sleep-inducing action of oleamide. Neurosci. Lett., 282, 13-16 (2000)
Giang, D.K.; Cravatt, B.F.: Molecular characterization of human and mouse fatty acid amide hydrolases. Proc. Natl. Acad. Sci. USA, 94, 2238-2242 (1997)
Boger, D.L.; Sato, H.; Lerner, A.E.; Hedrick, M.P.; Fecik, R.A.; Miyauchi, H.; Wilkie, G.D.; Austin, B.J.; Patricelli, M.P.; Cravatt, B.F.: Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. Proc. Natl. Acad. Sci. USA, 97, 5044-5049 (2000)
Bracey, M.H.; Hanson, M.A.; Masuda, K.R.; Stevens, R.C.; Cravatt, B.F.: Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling.. Science, 298, 1793-1796 (2002)
Quistad, G.B.; Sparks, S.E.; Casida, J.E.: Fatty acid amide hydrolase inhibition by neurotoxic organophosphorus pesticides. Toxicol. Appl. Pharmacol., 173, 48-55 (2001)
Karbarz, M.J.; Luo, L.; Chang, L.; Tham, C.S.; Palmer, J.A.; Wilson, S.J.; Wennerholm, M.L.; Brown, S.M.; Scott, B.P.; Apodaca, R.L.; Keith, J.M.; Wu, J.; Breitenbucher, J.G.; Chaplan, S.R.; Webb, M.: Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase. Anesth. Analg., 108, 316-329 (2009)
Kaczocha, M.; Glaser, S.T.; Chae, J.; Brown, D.A.; Deutsch, D.G.: Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2. J. Biol. Chem., 285, 2796-2806 (2010)
Wyffels, L.; Muccioli, G.G.; De Bruyne, S.; Moerman, L.; Sambre, J.; Lambert, D.M.; De Vos, F.: Synthesis, in vitro and in vivo evaluation, and radiolabeling of aryl anandamide analogues as candidate radioligands for in vivo imaging of fatty acid amide hydrolase in the brain. J. Med. Chem., 52, 4613-4622 (2009)
Onnis, V.; Congiu, C.; Bjoerklund, E.; Hempel, F.; Soederstroem, E.; Fowler, C.J.: Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors. J. Med. Chem., 53, 2286-2298 (2010)
Lever, I.J.; Robinson, M.; Cibelli, M.; Paule, C.; Santha, P.; Yee, L.; Hunt, S.P.; Cravatt, B.F.; Elphick, M.R.; Nagy, I.; Rice, A.S.: Localization of the endocannabinoid-degrading enzyme fatty acid amide hydrolase in rat dorsal root ganglion cells and its regulation after peripheral nerve injury. J. Neurosci., 29, 3766-3780 (2009)
Naidu, P.S.; Kinsey, S.G.; Guo, T.L.; Cravatt, B.F.; Lichtman, A.H.: Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase. J. Pharmacol. Exp. Ther., 334, 182-190 (2010)
Glaser, S.T.; Kaczocha, M.: Temporal changes in mouse brain fatty acid amide hydrolase activity. Neuroscience, 163, 594-600 (2009)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schomburg, D., Schomburg, I. (2013). fatty acid amide hydrolase 3.5.1.99. In: Schomburg, D., Schomburg, I. (eds) Class 3.4–6 Hydrolases, Lyases, Isomerases, Ligases. Springer Handbook of Enzymes, vol 10. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-36260-6_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-36260-6_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-36259-0
Online ISBN: 978-3-642-36260-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)